These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29325906)

  • 1. Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.
    Baulina N; Kulakova O; Kiselev I; Osmak G; Popova E; Boyko A; Favorova O
    J Neuroimmunol; 2018 Apr; 317():67-76. PubMed ID: 29325906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders.
    Perdaens O; Dang HA; D'Auria L; van Pesch V
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32033981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
    Waschbisch A; Atiya M; Linker RA; Potapov S; Schwab S; Derfuss T
    PLoS One; 2011; 6(9):e24604. PubMed ID: 21949733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
    Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP
    Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis.
    Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM
    Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability.
    Niwald M; Migdalska-Sęk M; Brzeziańska-Lasota E; Miller E
    J Mol Neurosci; 2017 Dec; 63(3-4):275-282. PubMed ID: 29043654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
    Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
    Front Immunol; 2018; 9():449. PubMed ID: 29559981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.
    Torabi S; Tamaddon M; Asadolahi M; Shokri G; Tavakoli R; Tasharrofi N; Rezaei R; Tavakolpour V; Sazegar H; Kouhkan F
    Immunogenetics; 2019 Feb; 71(2):87-95. PubMed ID: 30310937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNAs from
    Baulina N; Osmak G; Kiselev I; Popova E; Boyko A; Kulakova O; Favorova O
    Cells; 2019 Feb; 8(2):. PubMed ID: 30743997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IL-10-Regulating MicroRNAs in Peripheral Blood Mononuclear Cells with the Pathogenesis of Autoimmune Thyroid Disease.
    Takuse Y; Watanabe M; Inoue N; Ozaki R; Ohtsu H; Saeki M; Katsumata Y; Hidaka Y; Iwatani Y
    Immunol Invest; 2017 Aug; 46(6):590-602. PubMed ID: 28742402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of IL-17/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis.
    Balkan E; Bilge N
    Neurol Res; 2021 Sep; 43(9):778-783. PubMed ID: 34130607
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.
    Sedeeq MS; El-Nahrery EMA; Shalaby N; Hussein M; Shehata H; El Aal RA; Abdel Ghaffar NF; Mohamed MM
    J Neurol Sci; 2019 Aug; 403():92-96. PubMed ID: 31238191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.